Literature DB >> 29134278

Management of biochemically recurrent prostate cancer: molecular imaging perspective.

Alberto Martinez Lorca1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29134278     DOI： 10.1007/s00345-017-2127-0

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  3 in total

1.  18F-PSMA-1007 PET/CT Detects Micrometastases in a Patient With Biochemically Recurrent Prostate Cancer.

Authors:  Frederik L Giesel; Claudia Kesch; Mijin Yun; Jens Cardinale; Uwe Haberkorn; Klaus Kopka; Clemens Kratochwil; Boris A Hadaschik
Journal:  Clin Genitourin Cancer       Date:  2016-12-29       Impact factor: 2.872

2.  Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy-What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression?

Authors:  Amir Toussi; Suzanne B Stewart-Merrill; Stephen A Boorjian; Sarah P Psutka; R Houston Thompson; Igor Frank; Matthew K Tollefson; Matthew T Gettman; Rachel E Carlson; Laureano J Rangel; R Jeffrey Karnes
Journal:  J Urol       Date:  2015-12-23       Impact factor: 7.450

Review 3.  PET/CT Imaging and Radioimmunotherapy of Prostate Cancer.

Authors:  Kirsten Bouchelouche; Scott T Tagawa; Stanley J Goldsmith; Baris Turkbey; Jacek Capala; Peter Choyke
Journal:  Semin Nucl Med       Date:  2011-01       Impact factor: 4.446
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.